Citation Tools

Original research
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells

Download to a citation manager

Cite this article as:
Lee MY, Robbins Y, Sievers C, et al
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells